Unknown

Dataset Information

0

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry.


ABSTRACT: The only severe acute respiratory syndrome (SARS) vaccine currently being tested in clinical trial consists of inactivated severe acute respiratory syndrome-associate coronavirus (SARS-CoV). However, limited information is available about host immune responses induced by the inactivated SARS vaccine. In this study, we demonstrated that SARS-CoV inactivated by beta-propiolactone elicited high titers of antibodies in the immunized mice and rabbits that recognize the spike (S) protein, especially the receptor-binding domain (RBD) in the S1 region. The antisera from the immunized animals efficiently bound to the RBD and blocked binding of RBD to angiotensin-converting enzyme 2, the functional receptor on the susceptible cells for SARS-CoV. With a sensitive and quantitative single-cycle infection assay using pseudovirus bearing the SARS-CoV S protein, we demonstrated that mouse and rabbit antisera significantly inhibited S protein-mediated virus entry with mean 50% inhibitory titers of 1:7393 and 1:2060, respectively. These data suggest that the RBD of S protein is a major neutralization determinant in the inactivated SARS vaccine which can induce potent neutralizing antibodies to block SARS-CoV entry. However, caution should be taken in using the inactivated SARS-CoV as a vaccine since it may also cause harmful immune and/or inflammatory responses.

SUBMITTER: He Y 

PROVIDER: S-EPMC7092874 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC7115485 | biostudies-literature
| S-EPMC8632161 | biostudies-literature
| S-EPMC8203731 | biostudies-literature
| S-EPMC8486374 | biostudies-literature
| S-EPMC8080482 | biostudies-literature
| S-EPMC7781324 | biostudies-literature
| S-EPMC7805460 | biostudies-literature
| S-EPMC8234791 | biostudies-literature
| S-EPMC8427532 | biostudies-literature
| S-SCDT-EMBOR-2021-54305V1 | biostudies-other